Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TG6050 |
Synonyms | |
Therapy Description |
TG6050 is an oncolytic vaccinia virus engineered to express IL-12 and an anti-CTLA4 antibody, which potentially leads to enhanced antitumor immune response and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 694). |